Clinical Trial Update: Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing lenalidomide plus R-CHOP against placebo plus R-CHOP in untreated ABC-type diffuse large B-cell lymphoma has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• R-CHOP

Snippet

Sponsor: Celgene | Conditions: Lymphoma, Large B-Cell, Diffuse | Phase 3 | Status: COMPLETED | Results posted: 2020-03-30